It's Time to Move Forward

Corporate Headquarters

NanoString Technologies, Inc.
530 Fairview Avenue North
Seattle, WA 98109
USA

Directions and Map

Phone 888-358-NANO (888-358-6266)

Fax: 206-378-6288

E-mail: info@prosigna.com

Website: www.nanostring.com

Request Information

Area(s) of Interest
Check all that apply

Subscribe to our mailing list

Prosigna is indicated for in vitro diagnostic use in postmenopausal women with hormone receptor-positive, node-negative (Stage I or II), or node-positive (Stage II) breast cancer to be treated with adjuvant endocrine therapy for assessment of risk of distant recurrence of disease.